Antiproliferative Activity of a New Quinazolin-4(3<i>H</i>)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common lung cancer subtype. Although chemotherapy and targeted therapy are used for the treatment of patients with NSCLC, the survival rate remains very low. Recent findings suggested that aurora kinase A (AKA), a cell cycle regulator, is a potential ta...
Saved in:
Main Authors: | Ji Yun Lee (Author), Huarong Yang (Author), Donghwa Kim (Author), Kay Zin Kyaw (Author), Ruoci Hu (Author), Yanhua Fan (Author), Sang Kook Lee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aurora Kinase A Regulation by Cysteine Oxidative Modification
by: In-Gyun Lee, et al.
Published: (2023) -
Antibacterial Effects of Quinazolin-4(3<i>H</i>)-One Functionalized-Conjugated Silver Nanoparticles
by: Abdulkader Masri, et al.
Published: (2019) -
Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
by: Tebyan O. Mirgany, et al.
Published: (2021) -
Emerging roles of Aurora-A kinase in cancer therapy resistance
by: Dayong Zheng, et al.
Published: (2023) -
The significant others of aurora kinase a in cancer: combination is the key
by: Kumar Nikhil, et al.
Published: (2024)